Acute kidney injury in hospitalized patients with COVID-19: A Portuguese cohort.
Autores da FMUP
Participantes de fora da FMUP
- Gameiro J
- Oliveira J
- Marques F
- Bernardo J
- Costa C
- Carreiro C
- Braz S
- Lopes JA
Unidades de investigação
Abstract
INTRODUCTION: The incidence of acute kidney injury (AKI) in coronavirus disease 2019 (COVID-19) patients ranges from 0.5% to 35% and has been associated with worse prognosis. The purpose of this study was to evaluate the incidence, severity, duration, risk factors and prognosis of AKI in hospitalized patients with COVID-19. METHODS: We conducted a retrospective single-center analysis of 192 hospitalized COVID-19 patients from March to May of 2020. AKI was diagnosed using the Kidney Disease Improving Global Outcome (KDIGO) classification based on serum creatinine (SCr) criteria. Persistent and transient AKI were defined according to the Acute Disease Quality Initiative (ADQI) workgroup definitions. RESULTS: In this cohort of COVID-19 patients, 55.2% developed AKI (n = 106). The majority of AKI patients had persistent AKI (n = 64, 60.4%). Overall, in-hospital mortality was 18.2% (n = 35) and was higher in AKI patients (28.3% vs. 5.9%, p < 0.001, unadjusted OR 6.03 (2.22-16.37), p < 0.001). In this multivariate analysis, older age (adjusted OR 1.07 (95% CI 1.02-1.11), p = 0.004), lower Hb level (adjusted OR 0.78 (95% CI 0.60-0.98), p = 0.035), duration of AKI (adjusted OR 7.34 for persistent AKI (95% CI 2.37-22.72), p = 0.001) and severity of AKI (adjusted OR 2.65 per increase in KDIGO stage (95% CI 1.32-5.33), p = 0.006) were independent predictors of mortality. CONCLUSION: AKI was frequent in hospitalized patients with COVID-19. Persistent AKI and higher severity of AKI were independent predictors of in-hospital mortality.
© 2021 Sociedad Española de Nefrología. Published by Elsevier España, S.L.U.
Dados da publicação
- ISSN/ISSNe:
- 1989-2284, 0211-6995
- Tipo:
- Article
- Páginas:
- 689-698
Nefrologia Elsevier Espana
Documentos
- Não há documentos
Filiações
Keywords
- Acute kidney injury; COVID-19; Incidence; Mortality
Proyectos asociados
Prevalence and Characterisation of Asthma Patients According to Disease Severity in Portugal (EPI-ASTHMA) - NCT05169619
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Clínico Observacional (EPI-ASTHMA) . AstraZeneca . 2021
Utilização em estudos observacionais do Registo de Asma Grave Portugal.
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Observacional Académico (RAG) . 2020
Use of secondary data, health technology assessment methods and economic modelling applied to penicillin allergy
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Clínico Académico . 2020
Using different data sources for the identification of asthma patients and those at high risk of adverse outcomes
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Clínico Académico . 2020
Phenotypes of Chronic Diseases of the Airways: Towards Multidimensional Data -Driven Profiling
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Clínico Académico . 2020
Citar a publicação
Gameiro J,Fonseca JA,Oliveira J,Marques F,Bernardo J,Costa C,Carreiro C,Braz S,Lopes JA. Acute kidney injury in hospitalized patients with COVID-19: A Portuguese cohort. Nefrologia. 2021. 41. (6):p. 689-698. IF:3,084. (2).